반복영역 건너뛰기
지역메뉴 바로가기
주메뉴 바로가기
본문 바로가기

연구정보

[개발] Egypt - MINAPHARM expansion and renovation program

이집트 국외연구자료 연구보고서 - AFDB 발간일 : 2024-07-24 등록일 : 2024-08-16 원문링크

The project is a long-term investment program to develop, manufacture and commercialize additional biosimilar monoclonal antibodies targeting oncology and autoimmunity-based diseases, which is a highly unmet medical need in Africa. With the objective of building a biological Active Pharmaceutical Ingredients (API) hub to serve Africa and the Middle East (MEA) region, the investment program includes: (i) product development, construction, and the equipping of a second drug substance and drug product biotechnology facility in Cairo, Egypt (“XpandC”) and (ii) renovation of existing production lines.

본 페이지에 등재된 자료는 운영기관(KIEP)EMERiCs의 공식적인 입장을 대변하고 있지 않습니다.

목록